Challenges in translating tissue engineered heart valves into clinical practice: Will we finally be able to advance regenerative heart valves into clinical practice?

European Heart Journal

Volumn 38, Issue 9, 2017, Pages 619-621

  Emmert, Maximilian Y ^a,b,c   Hoerstrup, Simon P ^b,c,d  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Wyss Translational Center Zurich   (Switzerland)

^c Swiss Center for Regenerative Medicine   (Switzerland)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL PRACTICE; EUROPEAN MEDICINES AGENCY; EXTRACELLULAR MATRIX; FOLLOW UP; GOOD LABORATORY PRACTICE; GOOD MANUFACTURING PRACTICE; HEART VALVE; HEART VALVE REPLACEMENT; HUMAN; MEDICAL DEVICE REGULATION; PATIENT SELECTION; POLYMERIZATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SWITZERLAND; THERAPY EFFECT; TISSUE ENGINEERING; VALVULAR HEART DISEASE; BIOPROSTHESIS; FORECASTING; HEART VALVE PROSTHESIS; PROFESSIONAL PRACTICE; TRANSLATIONAL RESEARCH; TRENDS;

BIOPROSTHESIS; FORECASTING; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HUMANS; PROFESSIONAL PRACTICE; TISSUE ENGINEERING; TRANSLATIONAL MEDICAL RESEARCH;

EID: 85016204320     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehx075     Document Type: Article

References (0)